大核心梗死卒中血管内取栓术的长期(12个月)结局:SELECT2、TESLA、TENSION与LASTE试验的荟萃分析
该荟萃分析纳入4项随机对照试验共1229例大核心梗死(ASPECTS≤5)伴大血管闭塞患者,比较血管内取栓联合标准药物治疗与单纯标准药物治疗的长期结局。取栓组在功能独立(RR 3.91)、死亡率(RR 0.84)、总体生存(RR 1.17)和生活质量(SMD 0.55)方面均显著优于单纯药物治疗,但取栓组脑外血栓栓塞事件发生率更高(RR 7.94)。
要点
- 大核心梗死(ASPECTS≤5)伴大血管闭塞患者,取栓联合药物治疗较单纯药物治疗显著提高长期功能独立(RR 3.91)。
- 取栓组长期死亡率显著低于单纯药物治疗组(RR 0.84),总体生存(mRS 0-5)显著更优(RR 1.17)。
- 取栓组脑外血栓栓塞事件显著高于单纯药物治疗组(RR 7.94),其余并发症率无显著差异。
核心结论
- 对于大血管闭塞所致大核心梗死缺血性卒中患者,血管内取栓联合标准药物治疗较单纯标准药物治疗在功能结局、生存和生活质量方面显示出显著长期获益。
研究设计与样本
- 对4项随机对照试验(SELECT2、TESLA、TENSION、LASTE)进行荟萃分析,共纳入1229例患者(49%为女性),所有患者确诊大血管闭塞且ASPECTS≤5,比较血管内取栓联合标准药物治疗与单纯标准药物治疗,随访至1年。
诊断标准与关键数值
- 功能独立定义为改良Rankin量表(mRS)0-2分;总体生存定义为mRS 0-5分;大核心梗死定义依据ASPECTS≤5分。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 研究仅限随机对照试验数据,各试验间取栓技术和患者选择标准可能存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Endovascular thrombectomy (EVT) has demonstrated benefits over standard medical care (MC) in randomized controlled trials (RCTs) for patients with large vessel occlusion (LVO) and large infarct territory at 90 days. However, conflicting evidence exists regarding long-term safety and efficacy of EVT in these populations.
PURPOSE: To evaluate the clinical benefits of EVT in patients with large-core infarction through meta-analysis of high-quality RCT evidence with up to one-year follow-up.
DATA SOURCES: PubMed/MEDLINE, Web of Science, and Scopus databases.
STUDY SELECTION: RCTs involving patients with confirmed LVO and Alberta Stroke Program Early CT Score (Alberta Stroke Program Early CT Score [ASPECTS]) of ≤5, comparing EVT plus MC versus MC alone, with long-term outcome data.
DATA ANALYSIS: Meta-analysis of long-term functional and safety outcomes with subgroup analysis comparing long-term (≤1 year) versus short-term (≤90 days) data on functional outcomes, imaging modalities, and presentation window. Leave-one-out sensitivity analysis was performed to resolve heterogeneity.
DATA SYNTHESIS: Four RCTs comprising 1229 patients (49% female) were included. EVT demonstrated significant superiority over MC in functional independence (modified Rankin Scale [mRS] 0-2) (RR 3.91, 95% CI 2.7-5.66; P<0.001), mortality (RR 0.84, 95% CI 0.75-0.95; P = 0.005), overall survival (mRS0-5) (RR 1.17, 95% CI 1.05-1.31; P = 0.005), and quality of life (SMD 0.55, 95% CI 0.32-0.8; P<0.001) with up to one-year follow-up. No significant differences in complication rates were observed except for higher extra-cerebral thromboembolic events in the EVT group (RR 7.94, 95% CI 1.01-62.2; P = 0.048).
LIMITATIONS: Study limited to RCT data with potential variations in thrombectomy techniques and patient selection criteria across trials.
CONCLUSIONS: In patients with ischemic stroke due to LVO with established large core infarct, EVT plus MC showed significant long-term benefits in functional outcomes, survival, and quality of life compared to MC alone.
引用
- Mortezaei A, Essibayi MA, Abdelsalam A, et al. Long-Term (12 Months) Outcomes of Endovascular Thrombectomy for Large Core Stroke: A Meta-Analysis of SELECT2, TESLA, TENSION, and LASTE Trials. AJNR Am J Neuroradiol. 2025. PMID: 40139903. doi:10.3174/ajnr.A8749
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。